Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

© 2026 Go Backs. All rights reserved.

Low RiskFDA Drug
Medications & Supplements/Prescription Drugs

SigmaPharm Laboratories LLC: Asenapine Sublingual Tablets Recalled for Incorrect Flavoring Formulation

Agency Publication Date: May 14, 2021
Share:
Sign in to monitor this recall

Summary

SigmaPharm Laboratories LLC has recalled approximately 15,052 bottles of Asenapine Sublingual Tablets (5 mg and 10 mg) because they were manufactured with the incorrect flavoring agent. The tablets were produced using artificial cherry flavor instead of the required artificial black cherry flavor. Consumers who use this prescription medication should continue to take their medicine but contact their healthcare provider or pharmacist regarding the substitution, as the medication was distributed nationwide in the US.

Risk

While this recall is classified as low risk, the product contains an incorrect flavoring agent not specified in the approved formulation, which may affect the taste or consumer experience.

What You Should Do

  1. Check your prescription bottle to see if it is Asenapine Sublingual Tablets, 5 mg or 10 mg, manufactured by Sigmapharm Laboratories, LLC.
  2. For 5 mg tablets (NDC 42794-016-10), check if your bottle matches lot numbers 2012501, 2012601, 2012701, or 2100701 with an expiration date of August 2022.
  3. For 10 mg tablets (NDC 42794-017-10), check if your bottle matches lot numbers 2012801, 2012901, 2013001, 2100501 (Exp AUG 2022) or lot number 2100101 (Exp NOV 2022).
  4. Contact your healthcare provider or pharmacist for guidance regarding this flavor formulation error.
  5. Return any unused product to your pharmacy for a refund and contact SigmaPharm Laboratories LLC at their Bensalem, PA location for further instructions.
  6. For additional questions, contact the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls.

Your Remedy Options

💰Full Refund

Contact healthcare provider and return to pharmacy.

How to: Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund

Affected Products

Product: Asenapine Sublingual Tablets, 5 mg, 60 Tablets
Model:
NDC 42794-016-10
Recall #: D-0379-2021
Lot Numbers:
2012501 (Exp. AUG 2022)
2012601 (Exp. AUG 2022)
2012701 (Exp. AUG 2022)
2100701 (Exp. AUG 2022)
Date Ranges: Expiration August 2022
Product: Asenapine Sublingual Tablets, 10 mg, 60 Tablets
Model:
NDC 42794-017-10
Recall #: D-0380-2021
Lot Numbers:
2012801 (Exp AUG 2022)
2012901 (Exp AUG 2022)
2013001 (Exp AUG 2022)
2100501 (Exp AUG 2022)
2100101 (Exp NOV 2022)
Date Ranges: Expiration August 2022, Expiration November 2022

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 87748
Status: Resolved
Manufacturer: SigmaPharm Laboratories LLC
Sold By: Pharmacies nationwide
Manufactured In: United States
Units Affected: 2 products (6266 bottles; 8786 bottles)
Distributed To: Nationwide

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.